CPQ Cancer

[oncoresearch@cientjournals.com]                                                                                    Special Submissions to COVID Issue

Category: Gold Open Access                           Indexing Sites: Google Scholar, Click to view PublonsClick to view                     Current Issue: Volume 3 Issue 1
  Frequency: Bimonthly                                     Article Submission: 28 August 2020                             Upcoming Release: 07 September 2020
Honourable Reviewers of Current Articles: Dr. Emeka Taye Umezurike, Dr. Tarek Mohamed Kamal Motawi, Dr. Erisa Kola, Dr. Sicong Zhang, Dr. Giulio Tarro & Dr. Chrow Khurshid

Cancers are often managed through technological advancements with the help of multi-disciplinary cancer conferences where medical oncologists, surgical oncologists, radiation oncologists, pathologists, radiologists and organ specific oncologists meet to find the best possible management for an individual patient considering the physical, social, psychological, emotional and financial status of the patient. Valuable, important updates on behalf of oncologists with respect to the latest advancements in oncology, enables the management of cancer. Clinical trials in respective aspects are very essential for all the patients in whom cancer progresses and for whom no standard of care treatment options are available. In certain circumstances, an oncologist can mean the difference between life and death.

Cancer research enables to identify the causes and to develop strategies for prevention, diagnosis, treatment, and also to improve the performance of clinical trials to evaluate and compare the applications of various cancer treatments.

Journal Features

    • Immediate response towards the articles received.
    • Accepts papers from all areas of Cancer.
    • Providing rapid update regarding articles.
    • Presence of pertinent Editors and Reviewers.
    • Prompt peer review and decisions upon papers.
    • Comprehensive review through Editors and Reviewers with proficiency in the associated field.
    • Comfortable online and e-mail submission.
    • Fair decision making and ethics to ensure every decision is fair and transparent.
    • Grant of publication certificate to the authors.
    • “Best Article of Issue” certificate after each issue release.

Aim and Scope

Subject areas include, but are not restricted to the following fields:

Anticancer Agents, Apoptosis, Biomarkers & Treatment, Cancer Biology, Cancer Informatics, Cancer related Ethics, Cancer Toxicology, Carcinogenesis, Cell, Molecular & Stem Cell Biology, Cellular Oncology, Diagnostics, Drug Discovery & Delivery, Epidemiology & Prevention, Epidemiology and Cancer Prevention, Genetics and Epigenetics, Genetics, Genomics & Proteomics, Immunotherapy, Inflammation & Virology, Kaposi Sarcoma, Leukaemia, Metabolism, Molecular Cancer, Mutagenesis, Myeloma Cells, Oncogenes, Pathology, Predictive Markers, Radiation Oncology, Resistance and Metastasis, Tumour Microenvironment, Tumour Necrosis.

The desire of CPQ Cancer is to publish articles in all related aspects.

Latest Articles

Immunotherapy in Colorectal Cancer: A Promising Avenue?

Danielle Hebert BS#, Kayla Flewelling BS#, Najiha Farooqi MD & Mohamed Kamel, K. MD*

Advancements in immunotherapy, particularly immune checkpoint inhibitors, have revolutionized the treatment of metastatic colorectal cancer (mCRC). However, the efficacy of available immunotherapeutic agents is largely limited to tumors with DNA mismatch repair-deficient (dMMR) and/or those with microsatellite instability-high (MSI-H) mCRC. [...] READ MORE

View Full Text | Download PDF

Effect of the COVID-19 Pandemic on Cancer Treatment

Yanshan Ge1,2 & Minghua Wu1,3*

Since being identified as a public health emergency of major international concern, the outbreak of coronavirus disease (COVID-19) in 2019 has rapidly spread globally and has now been declared a pandemic by the World Health Organization (WHO). COVID- 19 has the characteristics of rapid spread from person to person. Many cancer patients often go to the hospital for treatment and disease monitoring. [...] READ MORE

View Full Text | Download PDF

The Impact of COVID-19 on Cancer Care and Research

Winston Wong, PharmD

No one predicted what the impact of COVID-19 upon globe would have been. The impact has been devastating, from a humanistic as well as from healthcare perspective. However, I am constantly reminded that no matter where the final numbers tally out to with respect to the human tragedy, COVID-19 thus far is not even close to the Great Flu Epidemic in 1917 during World War I. [...] READ MORE

View Full Text | Download PDF

A Novel Bioinformatic Approach for Large Deletion Detection in Multiplex Pcr-Based Ngs Assays

Fatemeh Abbaszadeh*, Shaza Abu Sirriya, Bincy Mathew, Ramin Badii, Vasiliki Chini, Zafar Nawaz & Susanna Akiki

Next-generation sequencing (NGS) has changed genetic diagnostics due to its high throughput, speed, and cost-effectiveness. This paper describes the challenges that were faced in detection of the frameshift variant c.1175_1214del in the BRCA1 gene, undetectable by CNV analysis, using Oncomine BRCA Research Assay (OBRA) and Ion Torrent platform. [...] READ MORE

View Full Text | Download PDF

Consequences of Blood Loss in Cardiothoracic Surgery

Massimo Baudo1*, Mohamed Rahouma2*, Mahmoud Morsi3, Yongle Ruan4, Sherif Khairallah2, Mohamed Kamel2, Galal Ghaly2, Ali Cheriat, N.5, Mohamed Hossny6, Omnia Mohamed7 & Abdelrahman Mohamed2

Efforts to minimize perioperative blood loss in surgery in order to improve short and long- term outcome should be made, as implications extend considerably beyond the perioperative period. Minimally invasive approaches are associated with less bleeding. [...] READ MORE

View Full Text | Download PDF

Evaluation of Clinical Manifestations and Their Effect on the Prognosis of Lung Cancer Patients

Halil Yanardag1, Cuneyt Tetikkurt2*, Cigdem Papila3, Muammer Bilir1 & Seza Tetikkurt4

Survival of lung cancer patients are affected by many different factors that are extremely variable for each individual. The prognosis of lung cancer primarily depends upon the tumor type, patient immunity and treatment. The objective of our study was to determine the influence of patient symptoms, laboratory findings, imaging modalities and histopathologic tumor features on the prognostic outcome of lung cancer patients. [...] READ MORE

View Full Text | Download PDF

The Formula of the Waste of Cholesterol Represents a New Hope for Re - RPG- HERB2 3+ Breast Cancer with Negative Waste of Cholesterol: Case Report

Lazo, R.1*, Cabrera, G.2, Jiménez, U.3, Rodríguez, M.4 & Lazo Alina, M.5

The hormone - dependence of breast cancer has been established for over a century but new investigations in its knowledge have gone away introducing with the step of years. Estrogen and progesterone receptors have been standards for the guide of treatment, but recently waste of cholesterol has emerged as a new perspective for the guide of treatment. [...] READ MORE

View Full Text | Download PDF

Evolving Insights into Brain Metastases in Patients with Oncogene Mutation-Driven Non-Small Cell Lung Cancer (NSCLC)

Adam Sholi, N.1, Iyan Younus2, Najiha Farooqi3 & Mohamed Kamel3*

Brain metastases (BM) frequently develop in patients with non-small cell lung cancer (NSCLC) with a higher incidence observed in patients with oncogenic driver mutations. Management strategies for BM are rapidly evolving to reflect the advancements in lung cancer biology and the recent application of novel molecular and immunotherapies in NSCLC. [...] READ MORE

View Full Text | Download PDF

Alterations in Serum VEGF Levels After Endocrine Therapy in Breast Cancer

Mohammad-Taher Moradi1, Mehrdad Payandeh2* & Mohammad Reza Ashrafi-Kooshk 3

Angiogenesis has been suggested as a potential target for anticancer treatment, either by blocking of angiogenic factors production or by blocking of endothelial cell proliferation. The effect of preoperative chemoendocrine therapy is indefinite in the regulation of angiogenic factors, but reports propose that several anticancer drugs have antiangiogenic activity. [...] READ MORE

View Full Text | Download PDF

Reactive Oxygen Species (ROS) in Cancer: Review Article

Gehan Abdel Naser Abdel Rahman

Cancer is one of the major heterogeneous disease with high morbidity and mortality with poor prognosis. Elevated levels of reactive oxygen species (ROS), alteration in redox balance, and deregulated redox signaling are common hallmarks of cancer progression and resistance to treatment. Mitochondria contribute mainly in the generation of ROS during oxidative phosphorylation. [...] READ MORE

View Full Text | Download PDF

Total Articles Published


Track Your Article


Cient Periodique is a ‘Gold’ open access publisher that aspires to offer absolute free, unrestricted access to the valuable research information

We welcome all the eminent authors to submit your valuable paper

Cient Periodique invites the participation of honourable Editors and Authors

CPQ Journals provide Certificates for publication

Cient Periodique also offers memberships for potential Authors

Best Articles will be appreciated with the provision of corresponding Certificate